ICD-10-CM Billable Code

H35.733

Hemorrhagic detachment of retinal pigment epithelium, bilateral

Clinical Classification Guidelines

Medical Intelligence & Overview

Hemorrhagic detachment of the retinal pigment epithelium is a rare eye condition affecting both eye's layers. This condition involves bleeding beneath the retinal pigment epithelium, a layer of cells crucial for nourishing the retina and maintaining eye health. When this layer detaches due to bleeding, it can impact vision and eye function. Although uncommon, understanding the causes, symptoms, and potential treatments can help individuals recognize the significance of early detection and management.

Causes & Symptoms

Clinical Causes: Age-related changes leading to weakening of blood vessels High blood pressure (hypertension) increasing likelihood of bleeding Blood vessel disorders, such as diabetic retinopathy or hypertensive retinopathy Trauma or injury to the eye Choroidal neovascularization, where abnormal blood vessels grow beneath the retina Blood clotting disorders that increase bleeding risks Certain inflammatory eye conditions

Key Symptoms: Sudden vision changes, such as blurred or distorted sight Shadow or dark curtain appearing across part of the visual field Flashes of light or floaters in the vision Decreased visual acuity, making it difficult to see fine details Possible discomfort or a feeling of pressure in the eye

Diagnostic & Treatment

Diagnosis Path: Optical coherence tomography (OCT) to obtain detailed images of the retina and pigment epithelium Fluorescein angiography to examine blood flow and identify leaking vessels Indirect ophthalmoscopy to assess the overall health of the retina and underlying layers

Treatment Protocols: Observation and regular monitoring for minor cases with no significant vision loss Laser therapy to seal leaking blood vessels or prevent further bleeding Photodynamic therapy using special medications and light to target abnormal vessels Intravitreal injections of medications, such as anti-vascular endothelial growth factor (anti-VEGF) agents, to control abnormal vessel growth and reduce bleeding Addressing underlying systemic conditions, like controlling blood pressure or blood sugar levels

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is H35.733 a billable ICD-10 code?
Yes, H35.733 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report H35.733?
Clinical documentation must specify the nature of Hemorrhagic detachment of retinal pigment epithelium, bilateral and any associated comorbidities for accurate reporting.

Cite this Clinical Reference